Candriam Luxembourg S.C.A. grew its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 4.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 261,777 shares of the company’s stock after purchasing an additional 10,418 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Express Scripts Holding were worth $16,576,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of ESRX. Bradley Foster & Sargent Inc. CT boosted its position in shares of Express Scripts Holding by 13.0% in the 3rd quarter. Bradley Foster & Sargent Inc. CT now owns 27,678 shares of the company’s stock worth $1,753,000 after buying an additional 3,186 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its position in shares of Express Scripts Holding by 17.0% in the 3rd quarter. Oregon Public Employees Retirement Fund now owns 204,551 shares of the company’s stock worth $12,952,000 after buying an additional 29,779 shares in the last quarter. Schaper Benz & Wise Investment Counsel Inc. WI boosted its position in shares of Express Scripts Holding by 8.6% in the 3rd quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 94,730 shares of the company’s stock worth $5,998,000 after buying an additional 7,485 shares in the last quarter. Boston Partners boosted its position in shares of Express Scripts Holding by 8.0% in the 3rd quarter. Boston Partners now owns 837,454 shares of the company’s stock worth $53,028,000 after buying an additional 62,359 shares in the last quarter. Finally, Nicolet Bankshares Inc. boosted its position in shares of Express Scripts Holding by 12.9% in the 3rd quarter. Nicolet Bankshares Inc. now owns 12,829 shares of the company’s stock worth $812,000 after buying an additional 1,467 shares in the last quarter. Institutional investors own 90.30% of the company’s stock.

Express Scripts Holding Company (NASDAQ:ESRX) traded down $0.70 during midday trading on Friday, hitting $60.05. 3,600,905 shares of the stock were exchanged, compared to its average volume of 4,326,750. Express Scripts Holding Company has a one year low of $55.80 and a one year high of $77.50. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. The firm has a market cap of $34,407.16, a P/E ratio of 8.88, a P/E/G ratio of 0.90 and a beta of 0.88.

Express Scripts Holding (NASDAQ:ESRX) last posted its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, meeting the Zacks’ consensus estimate of $1.90. Express Scripts Holding had a net margin of 3.64% and a return on equity of 25.46%. The company had revenue of $24.68 billion during the quarter, compared to the consensus estimate of $25.68 billion. During the same quarter in the prior year, the company posted $1.74 EPS. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. analysts expect that Express Scripts Holding Company will post 7.01 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/express-scripts-holding-company-esrx-shares-bought-by-candriam-luxembourg-s-c-a/1696068.html.

ESRX has been the topic of several recent research reports. Needham & Company LLC initiated coverage on shares of Express Scripts Holding in a research report on Friday, July 21st. They issued a “hold” rating on the stock. BidaskClub lowered shares of Express Scripts Holding from a “sell” rating to a “strong sell” rating in a research report on Friday, August 4th. Morgan Stanley boosted their price objective on shares of Express Scripts Holding from $52.00 to $57.00 and gave the stock an “underweight” rating in a research report on Thursday, August 10th. Jefferies Group LLC set a $72.00 price objective on shares of Express Scripts Holding and gave the stock a “buy” rating in a research report on Tuesday, August 29th. Finally, Robert W. Baird reiterated a “hold” rating and issued a $56.00 price objective on shares of Express Scripts Holding in a research report on Friday, September 1st. Seven research analysts have rated the stock with a sell rating, ten have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $69.53.

In related news, VP Everett Neville sold 1,163 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the sale, the vice president now owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Phyllis S. Anderson sold 643 shares of the stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total transaction of $40,103.91. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,284 shares of company stock valued at $397,421. Corporate insiders own 0.68% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.